Shanghai Twisun Bio-pharm Co., Ltd. is a leading professional hi-tech manufacturer of APIs and intermediates, special chemicals and CRO, which was established in Shanghai Jinshan Fine Chemical Industry Park in 2007. Twisun has acquired the Shanghai and State Ministry of Science and Technology Innovation Fund in 2009.

Twisun mainly involves in more than 40 key intermediates of 5 major categories which are Cardiovascular, Anti-cancer, anticoagulation,Antidiabetics, and Antidepressant etc. The main products includes: Tenofovir,Ticagrelor,Saxagliptin,Dabigatran Etexilate,Prasugrel, Rivaroxaban,Apixaban,Dapagliflozin,Paliperidone,Brinzolamide,Dorzolomide hydrochloride,Lapatinib,Nilotinib etc,which is newly developing API category and key intermediates. Besides, Twisun can offer professional services of chemistry and pharmacy efficiently.

Since its inception, Twisun pharm has always been adhering to the "Quality based, Customer first, Credit Management, Professional services" business purposes. The products are exported to Europe, USA, the Middle East, India, Southeast Asia and other regions. We have established a good and stable cooperation relationship with numerous pharmaceutical enterprises from both domestic and international. Our turnover is growing rapidly in double speed every year.

Twisun pharm has more than 3,000 square meters of multi-functional R&D center for chemistry and pharmacy. Having many sets of R&D and testing equipments like NMR, HPLC, LC-MS, and GC-MS etc. Twisun production base which covers 20,000 square meters GMP plant(Anhui Twisun Hi-Tech Pharmaceutical Co., Ltd) has been built and put into production. It has got ISO9000 certificates and can supply to customer with high-quality products which apply to international standards (ICH，Q7A etc.) now.Twisun also has a professional R&D team which comprised by 30 experts with many years experience in research and development. The professional research team and the development of specific project